Dark mode is part of the Premium plan.

It is included in the free trial.

Sign inSee Premium
Create a free account
Create a free account

Feeds › Patents

Patents

New US patents granted to public companies.

About this data
What it is
The US Patent and Trademark Office (USPTO) grants new patents every Tuesday. We match the companies named as owners to public companies.
Who files it
The USPTO publishes each grant.
How current
Grants are published every Tuesday, and we collect them weekly.
Worth knowing
A patent count says little about how valuable the patents are. We match owners to companies automatically, so a few may be missed.

All of this comes from public filings.

Source and freshness · Information, not investment advice (disclaimer).

Patents granted per week, last 12 weeks

05,00010.0K15.0KAug 25 · Patents granted: 8,093Aug 25Sep 1 · Patents granted: 6,519Sep 1Sep 8 · Patents granted: 6,822Sep 8Sep 15 · Patents granted: 6,983Sep 15Sep 22 · Patents granted: 5,563Sep 22Sep 29 · Patents granted: 6,286Sep 29Oct 6 · Patents granted: 7,272Oct 6Oct 13 · Patents granted: 8,528Oct 13Oct 20 · Patents granted: 7,948Oct 20Oct 27 · Patents granted: 5,467Oct 27Nov 3 · Patents granted: 10,067Nov 3Nov 10 · Patents granted: 8,414Nov 10
05,00010.0K15.0KAug 25 · Patents granted: 8,093Aug 25Sep 1 · Patents granted: 6,519Sep 1Sep 8 · Patents granted: 6,822Sep 8Sep 15 · Patents granted: 6,983Sep 15Sep 22 · Patents granted: 5,563Sep 22Sep 29 · Patents granted: 6,286Sep 29Oct 6 · Patents granted: 7,272Oct 6Oct 13 · Patents granted: 8,528Oct 13Oct 20 · Patents granted: 7,948Oct 20Oct 27 · Patents granted: 5,467Oct 27Nov 3 · Patents granted: 10,067Nov 3Nov 10 · Patents granted: 8,414Nov 10

Latest patent grants

Reset

Showing: ticker ARWR

Latest patent grants
GrantedPatentOwnerTypeSource
Sep 8, 202612729377
RNAi agents and compositions for inhibiting expression of angiopoieti…
ARWR
Arrowhead Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Jun 30, 202612667619
Integrin targeting ligands and uses thereof
ARWR
Arrowhead Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Jun 16, 202612655428
RNAi agents for inhibiting expression of Beta-ENaC, compositions ther…
ARWR
Arrowhead Pharmaceuticals, Inc.
utilityGoogle Patents ↗
May 19, 202612630826
RNAi agents for inhibiting expression of xanthine dehydrogenase (XDH)…
ARWR
Arrowhead Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Mar 24, 202612582718
Integrin targeting ligands and uses thereof
ARWR
Arrowhead Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Mar 24, 202612582668
Methods for the treatment of alpha-1 antitrypsin deficiency (AATD)
ARWR
Arrowhead Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Feb 17, 202612551569
RNAi agents for inhibiting expression of microtubule associated prote…
ARWR
Arrowhead Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Jan 27, 202612534728
RNAi agents for inhibiting expression of 17beta-HSD type 13 (HSD17B13…
ARWR
Arrowhead Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Jan 20, 202612527877
Anti-transferrin receptor antibodies, conjugates thereof, and uses th…
ARWR
Arrowhead Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Dec 23, 202512503696
RNAi agents for inhibiting expression of inhibin subunit beta E (INHB…
ARWR
Arrowhead Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Dec 2, 202512486502
RNAi agents for inhibiting expression of receptor for advanced glycat…
ARWR
Arrowhead Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Oct 14, 202512442002
RNAi agents for inhibiting expression of activin receptor-like kinase…
ARWR
Arrowhead Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Oct 14, 202512441756
5′-cyclo-phosphonate modified nucleotides
ARWR
Arrowhead Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Aug 5, 202512378558
RNAi agents for inhibiting expression of complement factor B (CFB), p…
ARWR
Arrowhead Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Jul 22, 202512365899
RNAi agents and compositions for inhibiting expression of apolipoprot…
ARWR
Arrowhead Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Jul 22, 202512365897
RNAi agents for inhibiting expression of mucin 5AC (MUC5AC), composit…
ARWR
Arrowhead Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Feb 11, 202512221610
RNAi agents for inhibiting expression of HIF-2 alpha (EPAS1), composi…
ARWR
Arrowhead Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Jan 7, 202512188017
Compositions and methods for inhibiting gene expression of alpha-1 an…
ARWR
Arrowhead Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Dec 24, 202412173086
Alpha-v beta-6 integrin ligands and uses thereof
ARWR
Arrowhead Pharmaceuticals, Inc.
utilityGoogle Patents ↗

19 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:11 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Clinical trial updates · FDA approvals and clearances